sur Lobe Sciences Ltd. (CVE:LOBE)
Lobe Sciences Ltd. Partners with ArcStone for Market Strategy
Lobe Sciences Ltd., a biopharmaceutical firm, announced its partnership with ArcStone Securities and Investments Corp. This agreement aims to boost Lobe's presence in North American capital markets. ArcStone will provide advisory services to enhance Lobe's investor relations and strategic market positioning. The collaboration supports Lobe's commitment to generating shareholder value through scientific advances and commercialization.
Dr. Fred D. Sancilio, Lobe Sciences' CEO, emphasized ArcStone's influence in Canadian and U.S. financial environments, which he believes will further Lobe's ongoing projects. Steve Kann of ArcStone expressed enthusiasm, noting Lobe's innovative pipeline addressing unmet medical needs.
The partnership reflects Lobe's strategy to fortify its market engagement immediately.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Lobe Sciences Ltd.